Kenneth C. Cundy
2014 - CohBar
In 2014, Kenneth C. Cundy earned a total compensation of $470.2K as Chief Scientific Officer at CohBar.
Compensation breakdown
| Option Awards | $441,352 |
|---|---|
| Salary | $28,846 |
| Total | $470,198 |
Cundy received $441.4K in option awards, accounting for 94% of the total pay in 2014.
Cundy also received $28.8K in salary.
Rankings
In 2014, Kenneth C. Cundy's compensation ranked 10,472nd out of 13,032 executives tracked by ExecPay. In other words, Cundy earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,472 out of 13,032 | 20th |
Division Manufacturing | 3,982 out of 4,966 | 20th |
Major group Chemicals And Allied Products | 1,371 out of 1,686 | 19th |
Industry group Drugs | 1,098 out of 1,365 | 20th |
Industry Pharmaceutical Preparations | 840 out of 1,043 | 20th |
Source: SEC filing on April 29, 2015.
Cundy's colleagues
We found two more compensation records of executives who worked with Kenneth C. Cundy at CohBar in 2014.
News
Anebulo Pharmaceuticals CEO Simon Allen's 2023 pay falls 63% to $778K
October 30, 2023
Anebulo Pharmaceuticals CEO Simon Allen receives $2.1M in 2022
October 17, 2022
CohBar CEO Joseph Sarret receives $3.2M in 2021
April 22, 2022
CohBar CEO Steven Engle receives $2.4M in 2019
April 29, 2020
CohBar CEO Philippe Calais receives $1.6M in 2018
April 24, 2019